Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter

IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

See all formats and pricing
More options …
Volume 38, Issue 9


Drug-Metabolizing Enzymes, Polymorphisms and Interindividual Response to Environmental Toxicants

Daniel W. Nebert
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2000.124


Individual risk of toxicity or cancer reflects the amount of exposure to environmental agents, combined with one's underlying genetic predisposition. More than six dozen human ecogenetic polymorphisms have been described; whereas some of these have been demonstrated to be associated with altered risks of toxicity or cancer, others presently remain equivocal and require further study. Thus, genetic differences in the regulation, expression and activity of “environmental susceptibility genes” can be decisive in defining susceptibility to toxicity or cancer.

“Drug-metabolizing enzymes” (DMEs) are regarded as one class of environmental susceptibility genes. DME genes have actually existed on this planet for more than 2.5 billion years, and might more appropriately be named “effector-metabolizing enzymes.” Receptors controlling DME levels have been called “DME receptors.” DMEs have functioned in many critical life processes in prokaryotes and, more recently, in countless basic functions in plants and animals—events that evolved long before the existence of pharmaceutical companies and apothecaries. DME genes exist in every eukaryotic cell and probably in all prokaryotes. Virtually all environmental agents act as either agonists or antagonists—in competing with endogenous ligands that bind to DME receptors and/or competing as substrates for the DMEs. Over the past decade it has become clear that each of us has our own “individual fingerprint” of unique alleles coding for DMEs. The underlying genetic predisposition of each patient will reflect combinations of poor- and extensive-metabolizer phenotypes; if these enzymes cooperate in the same metabolic pathway for any given drug or environmental agent, such ecogenetic variability might be synergistic and lead to as much as 30- or >40-fold differences in activation or degradation. The end result can be large interindividual differences in risk of environmentally caused toxicity or cancer.

About the article

Published Online: 2005-06-01

Published in Print: 2000-09-18

Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 38, Issue 9, Pages 857–861, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2000.124.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

K. S. Sugamori, D. Brenneman, S. Wong, A. Gaedigk, V. Yu, H. Abramovici, R. Rozmahel, and D. M. Grant
Drug Metabolism and Disposition, 2007, Volume 35, Number 7, Page 1064
Yan Zhong, Jing Wang, Steven G. Carmella, J. Bradley Hochalter, Diane Rauch, Andrew Oliver, Joni Jensen, Dorothy K. Hatsukami, Pramod Upadhyaya, Cheryl Zimmerman, and Stephen S. Hecht
Journal of Pharmacology and Experimental Therapeutics, 2011, Volume 338, Number 1, Page 353
Sally A Lorimore, Philip J Coates, and Eric G Wright
Oncogene, 2003, Volume 22, Number 45, Page 7058
Yusuf Y. Deeni, Sally H. Ibbotson, Julie A. Woods, C. Roland Wolf, Gillian Smith, and Giuseppe Novelli
PLoS ONE, 2013, Volume 8, Number 9, Page e75494
N. C. Sadler, P. Nandhikonda, B.-J. Webb-Robertson, C. Ansong, L. N. Anderson, J. N. Smith, R. A. Corley, and A. T. Wright
Drug Metabolism and Disposition, 2016, Volume 44, Number 7, Page 984
Mark R. Fielden, Jason B. Matthews, Kirsten C. Fertuck, Robert G. Halgren, and Tim R. Zacharewski
Critical Reviews in Toxicology, 2002, Volume 32, Number 2, Page 67
Audrey M. Cummings and Robert J. Kavlock
Critical Reviews in Toxicology, 2004, Volume 34, Number 6, Page 461
D. R. Geter, V. S. Bhat, B. B. Gollapudi, R. Sura, and S. D. Hester
Toxicological Sciences, 2014, Volume 138, Number 2, Page 425
Kristen A. Mitchell and Cornelis J. Elferink
Biochemical Pharmacology, 2009, Volume 77, Number 6, Page 947
Michael J. Blake, Lisa Castro, J. Steven Leeder, and Gregory L. Kearns
Seminars in Fetal and Neonatal Medicine, 2005, Volume 10, Number 2, Page 123
Noé Galván, Renata Jaskula-Sztul, Peter S MacWilliams, Charles J Czuprynski, and Colin R Jefcoate
Toxicology and Applied Pharmacology, 2003, Volume 193, Number 1, Page 84
Marilyn J. Aardema and James T. MacGregor
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2002, Volume 499, Number 1, Page 13
Gillian Smith, C Roland Wolf, Yusuf Y Deeni, Robert S Dawe, Alan T Evans, Muriel M Comrie, James Ferguson, and Sally H Ibbotson
The Lancet, 2003, Volume 361, Number 9366, Page 1336
Iris Grossman
Pharmacogenomics, 2007, Volume 8, Number 10, Page 1449
Gillian Smith, Muriel M. Comrie, C. Roland Wolf, Robert S. Dawe, Colin Clark, Alan T. Evans, James Ferguson, and Sally H. Ibbotson
Journal of Investigative Dermatology, 2003, Volume 121, Number 2, Page 390
G. Smith, S.H. Ibbotson, M.M. Comrie, R.S. Dawe, A. Bryden, J. Ferguson, and C.R. Wolf
British Journal of Dermatology, 2006, Volume 155, Number 2, Page 275
U. Stamer, B. Bayerer, and F. Stüber
Der Anaesthesist, 2006, Volume 55, Number 7, Page 746
Philip J Coates, Sally A Lorimore, Kirsten J Lindsay, and Eric G Wright
The Journal of Pathology, 2003, Volume 201, Number 3, Page 377
Mark J. Roth, Christian C. Abnet, Laura Lee Johnson, Steven D. Mark, Zhi Wei Dong, Philip R. Taylor, Sanford M. Dawsey, and You-Lin Qiao
Cancer Causes and Control, 2004, Volume 15, Number 10, Page 1077
Philip J Coates, Sally A Lorimore, and Eric G Wright
The Journal of Pathology, 2005, Volume 205, Number 2, Page 221
H. F. Merk and J. M. Baron
Der Hautarzt, 2004, Volume 55, Number 12, Page 1125

Comments (0)

Please log in or register to comment.
Log in